Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

148.21

+12.01 (8.82%)

At close: Jun 26, 2026, 4:00 PM EDT

148.49

+0.28 (0.19%)

Pre-market: Jun 29, 2026, 4:31 AM EDT

Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,126	1,296	132	-	-	-
Market Cap Growth	659.39%	880.67%	-	-	-	-
Enterprise Value	1,884	1,239	48.54	0	0	0
Last Close Price	148.21	104.67	12.00	-	-	-
PB Ratio	9.13	46.31	2.11	-	-	-
P/TBV Ratio	7.49	42.09	0.43	-	-	-
Debt / Equity Ratio	0.00	0.02	0	0	0.44	0.27
Net Debt / Equity Ratio	-1.12	-2.05	-1.33	0.10	-1.65	-2.05
Net Debt / EBITDA Ratio	5.73	1.49	5.93	0.62	0.69	2.01
Net Debt / FCF Ratio	8.98	2.29	7.71	0.54	0.76	-
Asset Turnover	-	0	0	0	0	0.24
Quick Ratio	28.73	5.11	7.14	3.11	1.92	2.39
Current Ratio	28.88	5.20	7.33	3.20	2.01	2.52
Return on Equity (ROE)	-37.88%	-92.10%	293.60%	-80.30%	-84.58%	-111.85%
Return on Assets (ROA)	-28.20%	-52.24%	-29.43%	-23.04%	-55.71%	-40.09%
Return on Invested Capital (ROIC)	-2459.46%	-1560.31%	-1425.18%	-54.26%	-146.36%	-111.50%
Return on Capital Employed (ROCE)	-30.10%	-62.06%	-34.64%	-37.04%	-85.70%	-55.77%
Buyback Yield / Dilution	-159.41%	-405.47%	-24.08%	0.00%	-122.35%	-18.48%
Total Shareholder Return	-159.41%	-405.47%	-24.08%	0.00%	-122.35%	-18.48%

SEC Filings: 10-K · 10-Q